Overview

A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic Acid

Status:
RECRUITING
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
This trial is a phase III study to evaluate the efficacy , tolerability, and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.
Phase:
PHASE3
Details
Lead Sponsor:
Gan & Lee Pharmaceuticals.
Treatments:
8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid